Helmy Eltoukhy
PhD, Stanford University. Chief Executive Officer of the Guardant Health precision oncology company, and provider of the GuardantINFORM real-world clinical-genomic platform. Guardant is sponsor of the GRECO-breast cancer study.
test content
test content here
More reads
Machine Learning For Jet Physics: New, Or Just Cool, Ideas
As I mentioned in yesterday's post, there is a workshop going on this week at Fermilab, where 110 attendees - mostly particle physicists, but some computer scientists are also present - discuss how…
Sing a Song of Politics
Sing a Song of Politics
I was testing my memory, trying to remember things that I learned way back when I was a small kid, and I realised that my most intense memories are of or related to poems and…
Addiction Cravings May Get Their Start Deep In The Right Side Of The Brain
INDIANAPOLIS - If you really want a drink right now, the source of your craving may be a pea-sized structure deep inside the right side of your brain, according to scientists at the Indiana…
Antibodies To Dengue May Alter Course Of Zika Virus Infection
Scientists at Emory Vaccine Center, in collaboration with investigators from Thailand, have found that people infected with dengue virus develop antibodies that cross-react with Zika virus.